UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 91

Sortiert nach

Carfilzomib and Dexamethasone in untreated symptomatic multiple myeloma

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e39-e40

2015

Volltextzugriff (PDF)

A phase I study of the addition of high-dose lenalidomide to melphalan conditioning for autologous stem-cell transplant in relapsed or refractory multiple myeloma

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e291-e292

2015

Volltextzugriff (PDF)

The Influence of STEMI Activation Time on First-Medical-Contact to Balloon Time: A Prospective Single Centre Study

Heart, lung & circulation, 2024-08, Vol.33, p.S573-S574

2024

Volltextzugriff (PDF)

IgM myeloma: A multicenter retrospective study of 134 patients

American journal of hematology, 2017-08, Vol.92 (8), p.746-751

2017

Volltextzugriff (PDF)

AVIAN DIVERSITY AND ITS ABUNDANCE IN THE KETHI VALLEY AREAS,THE NILGIRIS, WESTERN GHATS, TAMIL NADU

International journal of advanced research (Indore), 2017-08, Vol.5 (8), p.781-788

2017

Volltextzugriff (PDF)

Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients

Clinical lymphoma, myeloma and leukemia, 2017-12, Vol.17 (12), p.825-833

2017

Volltextzugriff (PDF)

Characteristics and outcomes of patients with multiple myeloma aged 21–40 years versus 41–60 years: a multi‐institutional case‐control study

British journal of haematology, 2016-12, Vol.175 (5), p.884-891

2016

Volltextzugriff (PDF)

Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases

Leukemia & lymphoma, 2019-01, Vol.60 (2), p.471-476

2019

Volltextzugriff (PDF)

The Adipocyte as an Important Target Cell for Trypanosoma cruzi Infection

The Journal of biological chemistry, 2005-06, Vol.280 (25), p.24085-24094

2005

Volltextzugriff (PDF)

The Kinetic Chain Revisited: New Concepts on Throwing Mechanics and Injury

PM & R, 2016-03, Vol.8 (3), p.S69-S77

2016

Volltextzugriff (PDF)

The Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of Ixabepilone: A First in Class Epothilone B Analogue in Late-Phase Clinical Development

Clinical cancer research, 2008-05, Vol.14 (9), p.2701-2709

2008

Volltextzugriff (PDF)

An evaluation of the role of bone marrow biopsy in patients with multiple myeloma who achieve an unconfirmed stringent complete remission

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.8144-8144

2010

Volltextzugriff (PDF)

Incidence of second primary malignancies (SPM) after 6-years follow-up of continuous lenalidomide in first-line treatment of multiple myeloma (MM)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8008-8008

2011

Volltextzugriff (PDF)

Utility of decreased FDG SUV as a response and prognostic indicator in multiple myeloma therapy with BiRD

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8607-8607

2008

Volltextzugriff (PDF)

High-Yield of CD34+ Cells With Bortezomib-Based Mobilization Regimen Is Associated With Specific Genomic Expression Patterns, Decrease in SDF-1 Plasma Levels and Up-Regulation of CXCR4 in Multiple Myeloma (MM) Patients

Biology of blood and marrow transplantation, 2011, Vol.17 (2), p.S179-S180

2011

Volltextzugriff (PDF)

Targeting Cdk4/6 in combination therapy of chemoresistant multiple myeloma

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8503-8503

2008

Volltextzugriff (PDF)

FDG-PET predicts disease burden in multiple myeloma

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.7619-7619

2006

Volltextzugriff (PDF)

Prediction of response to therapy with clarithromycin/lenalidomide/dexamethasone (BIRD) in multiple myeloma using FDG-PET

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.17530-17530

2006

Volltextzugriff (PDF)

Heterotopic Ossification in Civilians With Lower Limb Amputations

Archives of physical medicine and rehabilitation, 2014-09, Vol.95 (9), p.1710-1713

2014

Volltextzugriff (PDF)

Dermatofibrosarcoma protuberans: Neoadjuvant therapy with imatinib mesylate and use of plasma PDGF-B levels to monitor clinical response

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9049-9049

2004

Volltextzugriff (PDF)

Dermatofibrosarcoma protuberans: Neoadjuvant therapy with imatinib mesylate and use of plasma PDGF-B levels to monitor clinical response

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9049-9049

2004

Volltextzugriff (PDF)

173: Stem-Cell Collection Prior to Autologous Stem Cell Transplantation is Improved by Cyclophosphamide in Lenalidomide-Treated Patients with Multiple Myeloma

Biology of blood and marrow transplantation, 2008, Vol.14 (2), p.64-64

2008

Volltextzugriff (PDF)

Clarithromycin, lenalidomide and dexamethasone combination therapy as primary treatment of multiple myeloma

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.7545-7545

2006

Volltextzugriff (PDF)

BiRD (Biaxin®/Revlimid®/Dexamethasone) Combination Therapy (Rx) Results in High Complete Remissions (CR) and Overall Responses in Myeloma (MM) with Poor Prognostic Features

Blood, 2005-11, Vol.106 (11), p.642-642

2005

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Technology
(23)
Life Sciences & Biomedicine
(20)
Engineering
(17)
Humans
(17)
Exact Sciences And Technology
(12)
Male
(12)
Applied Sciences
(11)
Female
(10)
Materials Science
(10)
Engineering, Electrical & Electronic
(8)
Middle Aged
(8)
Physical Sciences
(8)
Adult
(7)
Materials Science, Multidisciplinary
(7)
Aged
(6)
Physical Medicine And Rehabilitation
(6)
Animals
(5)
Hematology
(5)
Hematology, Oncology And Palliative Medicine
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Carfilzomib and Dexamethasone in untreated symptomatic multiple myeloma

A phase I study of the addition of high-dose lenalidomide to melphalan conditioning for autologous stem-cell transplant in relapsed or refractory multiple myeloma

The Influence of STEMI Activation Time on First-Medical-Contact to Balloon Time: A Prospective Single Centre Study

IgM myeloma: A multicenter retrospective study of 134 patients

AVIAN DIVERSITY AND ITS ABUNDANCE IN THE KETHI VALLEY AREAS,THE NILGIRIS, WESTERN GHATS, TAMIL NADU

Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients

IgM Myeloma: A Multicenter Retrospective Study of 159 Patients

Characteristics and outcomes of patients with multiple myeloma aged 21–40 years versus 41–60 years: a multi‐institutional case‐control study

Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases

The Adipocyte as an Important Target Cell for Trypanosoma cruzi Infection

The Kinetic Chain Revisited: New Concepts on Throwing Mechanics and Injury

The Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of Ixabepilone: A First in Class Epothilone B Analogue in Late-Phase Clinical Development

An evaluation of the role of bone marrow biopsy in patients with multiple myeloma who achieve an unconfirmed stringent complete remission

Incidence of second primary malignancies (SPM) after 6-years follow-up of continuous lenalidomide in first-line treatment of multiple myeloma (MM)

Utility of decreased FDG SUV as a response and prognostic indicator in multiple myeloma therapy with BiRD

High-Yield of CD34+ Cells With Bortezomib-Based Mobilization Regimen Is Associated With Specific Genomic Expression Patterns, Decrease in SDF-1 Plasma Levels and Up-Regulation of CXCR4 in Multiple Myeloma (MM) Patients

Targeting Cdk4/6 in combination therapy of chemoresistant multiple myeloma

FDG-PET predicts disease burden in multiple myeloma

Prediction of response to therapy with clarithromycin/lenalidomide/dexamethasone (BIRD) in multiple myeloma using FDG-PET

Heterotopic Ossification in Civilians With Lower Limb Amputations

Dermatofibrosarcoma protuberans: Neoadjuvant therapy with imatinib mesylate and use of plasma PDGF-B levels to monitor clinical response

Dermatofibrosarcoma protuberans: Neoadjuvant therapy with imatinib mesylate and use of plasma PDGF-B levels to monitor clinical response

173: Stem-Cell Collection Prior to Autologous Stem Cell Transplantation is Improved by Cyclophosphamide in Lenalidomide-Treated Patients with Multiple Myeloma

Clarithromycin, lenalidomide and dexamethasone combination therapy as primary treatment of multiple myeloma

BiRD (Biaxin®/Revlimid®/Dexamethasone) Combination Therapy (Rx) Results in High Complete Remissions (CR) and Overall Responses in Myeloma (MM) with Poor Prognostic Features

Suchergebnisse filtern